Citation: C. Coulange, Evaluation of the safety of intravesical BCG therapy in France: analysis of serious adverse events notified over a three-year period. Commentary, PROG UROL, 11(3), 2001, pp. 465-465
Authors:
Zattara-Cannoni, H
Daniel, L
Roll, P
Coulange, C
Vagner-Capodano, AM
Citation: H. Zattara-cannoni et al., Molecular cytogenetics of t(X;1)(p11.2;q21) with complex rearrangements ina renal cell carcinoma, CANC GENET, 123(1), 2000, pp. 61-64
Authors:
Demoux, R
Lechevallier, E
Boubli, L
Cravello, L
Coulange, C
Citation: R. Demoux et al., Pelvic endometriosis with urological involvement. Therapeutic principles based on 2 cases., PROG UROL, 9(4), 1999, pp. 750-755
Authors:
Lechevallier, E
Eghazarian, C
Ortega, JC
Roux, F
Coulange, C
Citation: E. Lechevallier et al., Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen, UROLOGY, 54(5), 1999, pp. 857-861
Authors:
Lechevallier, E
Eghazarian, C
Ortega, JC
Daniel, L
Roux, F
Thirion, X
Coulange, C
Citation: E. Lechevallier et al., Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen, UROLOGY, 53(4), 1999, pp. 731-735
Authors:
Lechevallier, E
Dussol, B
Luccioni, A
Thirion, X
Vacher-Copomat, H
Jaber, K
Brunet, P
Leonetti, F
Lavelle, O
Coulange, C
Berland, Y
Citation: E. Lechevallier et al., Posttransplantation acute tubular necrosis: Risk factors and implications for graft survival, AM J KIDNEY, 32(6), 1998, pp. 984-991